One Sample, Many Answers



Life Sciences

Anzu investment:

June 2021

Providing research and clinical customers with a multi omic solution to enable greater insight from a single sample

A multi-modal, multi-plex, and multi-omics technology company developing a next generation quantitative and digital spatial platform for nucleic acid and protein assays with unprecedented levels of sensitivity and simultaneous analyte detection from a single specimen.

Interested in more information?

Complete the form below to get connected directly with the portfolio company